Cargando…

2444. Incidence of Daptomycin Toxicity Among Patients With Vancomycin-Resistant Enterococcus Blood Stream Infections

BACKGROUND: Daptomycin (DAP) is a lipopeptide antibiotic and is first-line treatment for infections caused by Vancomycin-resistant Enterococcus (VRE). DAP is considered a safe antimicrobial agent, most commonly causing elevation of CPK. The historical incidence of DAP toxicity reported in the litera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rios, Maria X Bueno, Shimose, Luis A, Athans, Vasilios, Bass, Stephanie, Otiso, Joshua, Li, Manshi, Wang, Xiaofeng, Duggal, Abhijit, Richter, Sandra S, Kovacs, Christopher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254815/ http://dx.doi.org/10.1093/ofid/ofy210.2097

Ejemplares similares

2441. Outcomes of Patients With Vancomycin-Resistant Enterococcus Blood Stream Infections (BSI) Treated With Daptomycin
por: Shimose, Luis A, et al.
Publicado: (2018)

Use of daptomycin and vancomycin in blood stream infections with PDR Acinetobacter Baumanii
por: Alexandropoulos, P, et al.
Publicado: (2015)

New Mutations in cls Lead to Daptomycin Resistance in a Clinical Vancomycin- and Daptomycin-Resistant Enterococcus faecium Strain
por: Li, Weiwei, et al.
Publicado: (2022)

Small RNAs in vancomycin-resistant Enterococcus faecium involved in daptomycin response and resistance
por: Sinel, Clara, et al.
Publicado: (2017)

Breakthrough daptomycin-, linezolid-, vancomycin-resistant Enterococcus faecium bacteremia during protracted daptomycin therapy: A case report
por: Pincus, Nathan B., et al.
Publicado: (2022)

Delay units MPS 2444 and 2833
por: Barbalat, O
Publicado: (1966)

Disposition of linezolid or daptomycin in Enterococcal bloodstream infections according to vancomycin resistant Enterococcus colonization
por: Short, Elizabeth, et al.
Publicado: (2014)

Risk Factors and Outcomes Associated With Acquisition of Daptomycin and Linezolid–Nonsusceptible Vancomycin-Resistant Enterococcus
por: Greene, Matthew H, et al.
Publicado: (2018)

Daptomycin treatment impacts resistance in off-target populations of vancomycin-resistant Enterococcus faecium
por: Kinnear, Clare L., et al.
Publicado: (2020)

Reduced Chlorhexidine and Daptomycin Susceptibility in Vancomycin-Resistant Enterococcus faecium after Serial Chlorhexidine Exposure
por: Bhardwaj, Pooja, et al.
Publicado: (2017)

Evolution and mutations predisposing to daptomycin resistance in vancomycin-resistant Enterococcus faecium ST736 strains
por: Wang, Guiqing, et al.
Publicado: (2018)

A retrospective clinical comparison of daptomycin vs daptomycin and a beta-lactam antibiotic for treating vancomycin-resistant Enterococcus faecium bloodstream infections
por: Chuang, Yu-Chung, et al.
Publicado: (2018)

Engineering of Streptoalloteichus tenebrarius 2444 for Sustainable Production of Tobramycin
por: Mitousis, Lena, et al.
Publicado: (2021)

Genetic Basis of Emerging Vancomycin, Linezolid, and Daptomycin Heteroresistance in a Case of Persistent Enterococcus faecium Bacteremia
por: Chacko, Kieran I., et al.
Publicado: (2018)

In Vitro Antimicrobial Activity of Fosfomycin, Vancomycin and Daptomycin Alone, and in Combination, Against Linezolid-Resistant Enterococcus faecalis
por: Yu, Wei, et al.
Publicado: (2020)

Daptomycin exposure precedes infection and/or colonization with daptomycin non-susceptible enterococcus
por: Storm, Jeremy C, et al.
Publicado: (2012)

1546. Efficacy of Daptomycin Combinations Against Daptomycin-Resistant Enterococcus faecium Differs by β-lactam
por: Kebriaei, Razieh, et al.
Publicado: (2019)

Daptomycin for a complicated urinary tract infection with vancomycin-resistant Enterococcus faecium in a renal transplant recipient
por: Eden, Gabriele, et al.
Publicado: (2012)

Daptomycin-Vancomycin–Resistant Enterococcus faecium Native Valve Endocarditis: Successfully Treated With Off-Label Quinupristin-Dalfopristin
por: Hussain, Khandakar, et al.
Publicado: (2016)

1221. Genomic Factors Affecting the Efficacy of Antimicrobial Therapy in Daptomycin-, Linezolid-, Vancomycin-Resistant Enterococcus faecium (DLVRE)
por: Gatesy, Samuel W, et al.
Publicado: (2021)

1825. Comparative Effectiveness of Ampicillin versus Vancomycin or Daptomycin for the Treatment of Ampicillin-Susceptible Enterococcus spp. Bloodstream Infections
por: Chua, Hubert C, et al.
Publicado: (2022)

Successful Treatment of Vancomycin-Resistant Enterococcus species Bone and Joint Infection with Daptomycin Plus Beta Lactam Agents
por: La, Yeon Ju, et al.
Publicado: (2022)

1399. Efficacy of Daptomycin Combination with β-Lactams for Daptomycin-resistant Enterococcus faecium Harboring LiaSR Substitutions
por: Kebriaei, Razieh, et al.
Publicado: (2018)

1250. Development of Linezolid and Daptomycin Resistance in Vancomycin Resistant Enterococcus faecium (VRE) during prolonged treatment for Intraabdominal Abscess
por: Al-Heeti, Omar, et al.
Publicado: (2021)

1611. Evaluating Clinical Outcomes and Efficacy of Daptomycin in Combination with a Beta-Lactam for the Treatment of Vancomycin-Resistant Enterococcus (VRE) Bacteremia
por: Irusta, Nerea, et al.
Publicado: (2020)

Daptomycin Resistance Occurs Predominantly in vanA-Type Vancomycin-Resistant Enterococcus faecium in Australasia and Is Associated With Heterogeneous and Novel Mutations
por: Li, Lucy, et al.
Publicado: (2021)

Comparison of the pharmacokinetic properties of vancomycin, linezolid, tigecyclin, and daptomycin
por: Estes, Kerry S, et al.
Publicado: (2010)

Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol
por: Zarogoulidis, Paul, et al.
Publicado: (2014)

A High Daptomycin Dose Is Associated with Better Bacterial Clearance in Infections Caused by Vancomycin-Resistant Enterococcus faecium Regardless of Daptomycin Minimum Inhibitory Concentration in a Rat Infective Endocarditis Model
por: Wang, Jann-Tay, et al.
Publicado: (2022)

1539. Dalbavancin, Vancomycin, and Daptomycin Alone and in Combination with Cefazolin Against Vancomycin Intermediate-Resistant (VISA) and Daptomycin Non-Susceptible (DNS) Staphylococcus aureus
por: Abdul-Mutakabbir, Jacinda, et al.
Publicado: (2019)

601. TelA and XpaC Are Novel Mediators of Daptomycin Resistance in Enterococcus faecium
por: Tran, Truc T, et al.
Publicado: (2019)

Two Cases of Vancomycin-Resistant Enterococcus faecium Bacteremia With Development of Daptomycin-Resistant Phenotype and its Detection Using Oxford Nanopore Sequencing
por: Udaondo, Zulema, et al.
Publicado: (2020)

Biofilm Time-Kill Curves to Assess the Bactericidal Activity of Daptomycin Combinations against Biofilm-Producing Vancomycin-Resistant Enterococcus faecium and faecalis
por: Barber, Katie E., et al.
Publicado: (2021)

Low Proportion of Linezolid and Daptomycin Resistance Among Bloodborne Vancomycin-Resistant Enterococcus faecium and Methicillin-Resistant Staphylococcus aureus Infections in Europe
por: Markwart, Robby, et al.
Publicado: (2021)

Daptomycin-Resistant Enterococcus Bacteremia Is Associated With Prior Daptomycin Use and Increased Mortality After Liver Transplantation
por: Lee, Rachael A, et al.
Publicado: (2022)

Noninvasive ventilation in acute exacerbation of COPD: Homer is close to shore
por: Hatipoğlu, Umur, et al.
Publicado: (2021)

Enterococcus faecalis and pathogenic streptococci inactivate daptomycin by releasing phospholipids
por: Ledger, Elizabeth V. K., et al.
Publicado: (2017)

Induction of Daptomycin Tolerance in Enterococcus faecalis by Fatty Acid Combinations
por: Brewer, William, et al.
Publicado: (2020)

1573. Daptomycin Resistant Enterococcus faecium: Combination Therapy Screening
por: Kebriaei, Razieh, et al.
Publicado: (2020)

The efficacy and safety of daptomycin vs. vancomycin for the treatment of cellulitis and erysipelas
por: Pertel, P E, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_q43u17ti1g3i941f3csemoi7eq